Coronary vasomotor tone in large epicardial coronary arteries with special emphasis on beta-adrenergic vasomotion, effects of beta-blockade
- PMID: 1982612
- DOI: 10.1007/978-3-662-11038-6_27
Coronary vasomotor tone in large epicardial coronary arteries with special emphasis on beta-adrenergic vasomotion, effects of beta-blockade
Abstract
Changes in coronary vasomotor tone of large epicardial coronary arteries today can be assessed quite accurately by exact measurements of coronary diameters applying computer assisted systems. The effect of various vasodilators (nitrates, calcium antagonists, EDRF-dependent compounds) was tested in this way. It appears that normal coronary artery segments reach a maximum of dilator reserve with an increase of luminal diameter of approximately 30-40%; different patterns of kinetics were, however, encountered. beta-Blocking agents, both non-selective (propranolol) and selective (atenolol), were found to lead to a gradual vasoconstriction, i.e., a decrease in diameter by approximately 20-25% over 20 min, an effect which is overcome by nitrates. New beta-blocking compounds with vasodilator properties, such as celiprolol, show no constriction. The vasoconstrictor effect of propranolol and atenolol may not only be due to the decrease of flow following the drop in myocardial oxygen consumption, but could also reflect an unopposed alpha-adrenergic tone. The clinical aspects of this observation are discussed.
Similar articles
-
Impact of exercise-induced coronary vasomotion on anti-ischemic therapy.Coron Artery Dis. 2000 Jun;11(4):363-9. doi: 10.1097/00019501-200006000-00011. Coron Artery Dis. 2000. PMID: 10860181 Review.
-
Insulin modulation of beta-adrenergic vasodilator pathway in human forearm.Circulation. 1996 Apr 1;93(7):1403-10. doi: 10.1161/01.cir.93.7.1403. Circulation. 1996. PMID: 8641030
-
Effect of atenolol and celiprolol on acetylcholine-induced coronary vasomotion in coronary artery disease.Am J Cardiol. 2000 Jan 15;85(2):172-7. doi: 10.1016/s0002-9149(99)00648-7. Am J Cardiol. 2000. PMID: 10955372 Clinical Trial.
-
Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease.Circulation. 1983 Jun;67(6):1178-85. doi: 10.1161/01.cir.67.6.1178. Circulation. 1983. PMID: 6133636
-
Neuronal control of coronary blood flow.Basic Res Cardiol. 1995 Mar-Apr;90(2):142-59. doi: 10.1007/BF00789444. Basic Res Cardiol. 1995. PMID: 7646417 Review.
Cited by
-
How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?Int J Card Imaging. 1998 Dec;14(6):357-72. doi: 10.1023/a:1006076409185. Int J Card Imaging. 1998. PMID: 10453390 Review.
-
Beta-blockers and coronary flow reserve: the importance of a vasodilatory action.Drugs. 2008;68(5):579-90. doi: 10.2165/00003495-200868050-00002. Drugs. 2008. PMID: 18370439 Review.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous